The aim of the study is to describe and analyze the most important causes that lead to postpartum hemorrhage. This research was carried out at The Bent al-Huda Hospital for Maternity and Children's Hospital in Nasiriyah, where the study included (63) cases of women with postpartum hemorrhage from the reviews of the hospital for the period from February 2020 to December 2020 as shown in the hospital records, and collected information for the study through a simple questionnaire, including information: age of women, place of residence, place of birth, type of birth and causes of hemorrhage. Age groups between (40-44) accounted for (22?),  (35-39), which are the highest age groups at risk of postpartum hemorrhage. The most frequent deliveries take place in the hospital, because natural or cesarean deliveries increase in this percentage.   The results of the current study also show that there is no difference between natural childbirth and caesarean section  with the occurrence of postpartum hemorrhage , that the condition of non-constriction of the uterus (inertia of uterus) constitutes (30%) and is considered the highest percentage among the causes of hemorrhage after birth, and then the causes such as the remnants of part of the placenta and the frequency of caesarean section by (16%), the use of accelerated medicines for childbirth and by percentage (14%) while the other causes came in low rates of cases postpartum hemorrhage.

After the emergency approval of different COVID-19 vaccines the administration of millions of doses, many concerns arise for adverse effects, especially in vulnerable groups such as diabetics. In this study, we investigate what effects different COVID vaccines could have on several biomarkers in diabetic patients and whether that raises a concern for this group or not. Materials and methods:  this study includes  two groups of diabetics each group consists of 20 participants  ; One of the groups under study, where they received the COVID-19 vaccine either AstraZeneca or  Pifizr-BioNTech vaccine and the other groups were controlled or the Pfizer-BioNTech vaccine, the other group-the control group- did not take any vaccine. Blood samples were taken from both groups about a week after the first  dose and statistical studies were conducted on the results. Results: Noticed an increase in all biomarkers. Increase in RBS could simply be due to immune response, same thing could be said for the CRP increase. Ferritin increase was not important; it was only apparent in three patients and that could be due to active infection. The increase in D-dimer levels was apparent in all patients and that raises the biggest concern. Conclusion: the biggest issue was seen in the rising of D-dimer levels because it raises concern about clotting disorders and heart disease which is already a concern for diabetic patients. Further investigation should be done and careful monitoring for clotting risks is necessary after the vaccine.